Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CX-046684 Cause Dyspnoea? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Dyspnoea have been filed in association with CX-046684. This represents 20.0% of all adverse event reports for CX-046684.

10
Reports of Dyspnoea with CX-046684
20.0%
of all CX-046684 reports
0
Deaths
3
Hospitalizations

How Dangerous Is Dyspnoea From CX-046684?

Of the 10 reports, 3 (30.0%) required hospitalization.

Is Dyspnoea Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CX-046684. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does CX-046684 Cause?

Fatigue (23) Off label use (15) Covid-19 (14) Headache (13) Asthenia (12) Muscular weakness (12) Pain in extremity (11) Dysphagia (10) Fall (10) Drug ineffective (9)

What Other Drugs Cause Dyspnoea?

ALBUTEROL (21,856) TREPROSTINIL (16,348) AMBRISENTAN (13,367) PREDNISONE (12,830) BUDESONIDE\FORMOTEROL (11,158) TIOTROPIUM (10,863) ADALIMUMAB (10,547) DUPILUMAB (10,310) FLUTICASONE\SALMETEROL (9,783) MEPOLIZUMAB (9,192)

Related Pages

CX-046684 Full Profile All Dyspnoea Reports All Drugs Causing Dyspnoea CX-046684 Demographics